NCT03176927

Brief Summary

There is a tremendous clinical need for a noninvasive technique that can assess gastric electrical activity and would be repeatable without any exposure to radiation. Investigators developed a new technique allowing to use noninvasive methods to assess bioelectrical activity in the gastrointestinal system. This has enabled to characterize the normal and pathologic physiology of the stomach through the use of noninvasive magnetogastrogram (MGG) records. Primary hypothesis for this proposal is that analysis of gastric slow wave uncoupling and propagation in multichannel MGG discriminates between normal and pathological gastric electrical activity. Eventually, investigators envision this research leading to new insights for gastrointestinal conditions such as gastroparesis, functional dyspepsia and chronic idiopathic nausea that would inform clinical management of these debilitating diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Dec 2012

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 28, 2012

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

April 5, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 6, 2017

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2021

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

8.4 years

First QC Date

April 5, 2017

Last Update Submit

April 20, 2026

Conditions

Keywords

magnetogastrogramgastroparesiselectrogastrogramgastric slow wave

Outcome Measures

Primary Outcomes (1)

  • Measurement of gastric slow wave activity in normal and diseased smooth muscle of the stomach

    1 day

Secondary Outcomes (4)

  • Measurement of gastric slow wave propagation velocity in gastroparesis patients

    1 day

  • Measurement of invasive serosal electromyogram before and after partial/total gastrectomy.

    day 1 and day 30

  • Measurement of noninvasive magnetogastrogram before and after partial/total gastrectomy.

    day 1 and day 30

  • Noninvasive measurement of gastric slow wave dysrhythmia in pediatric patients with nausea and functional dyspepsia

    1 day

Study Arms (5)

Gastroparesis

EXPERIMENTAL

magnetogastrogram Diabetes with and without gastroparesis ; Idiopathic gastroparesis

Diagnostic Test: magnetogastrogram

Gastrectomy

EXPERIMENTAL

magnetogastrogram Total or partial gastrectomy group

Diagnostic Test: magnetogastrogram

Functional dyspepsia

EXPERIMENTAL

magnetogastrogram Children with functional dyspepsia

Diagnostic Test: magnetogastrogram

Chronic nausea

EXPERIMENTAL

magnetogastrogram Children with chronic nausea

Diagnostic Test: magnetogastrogram

Control participants

EXPERIMENTAL

magnetogastrogram Group without any gastrointestinal diseases.

Diagnostic Test: magnetogastrogram

Interventions

magnetogastrogramDIAGNOSTIC_TEST
Chronic nauseaControl participantsFunctional dyspepsiaGastrectomyGastroparesis

Eligibility Criteria

Age12 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants between ages 12-80
  • Diabetic patients with gastroparesis, diabetic patients without gastroparesis and who are willing to have a gastric emptying test if they have not had one in the last 6 months and an IV inserted.
  • Patients with idiopathic gastroparesis
  • Total or partial gastrectomy patients
  • Children (ages 12-17) with functional dyspepsia
  • Children (ages 12-17) with chronic nausea

You may not qualify if:

  • Those with claustrophobia who cannot lie still under the SQUID for the length of time required.
  • Normal participants with known intestinal complications
  • Pregnant females (females who are able to have children will be given a pregnancy test).
  • Morbid obesity (these patients are presumably unable to lie under the current generation of SQUID devices).
  • Patients with a history of cardiac arrhythmias, taking anticoagulants, or greater than 80 years of age will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Related Publications (5)

  • Bradshaw LA, Cheng LK, Chung E, Obioha CB, Erickson JC, Gorman BL, Somarajan S, Richards WO. Diabetic gastroparesis alters the biomagnetic signature of the gastric slow wave. Neurogastroenterol Motil. 2016 Jun;28(6):837-48. doi: 10.1111/nmo.12780. Epub 2016 Feb 3.

  • Bradshaw LA, Kim JH, Somarajan S, Richards WO, Cheng LK. Characterization of Electrophysiological Propagation by Multichannel Sensors. IEEE Trans Biomed Eng. 2016 Aug;63(8):1751-9. doi: 10.1109/TBME.2015.2502065. Epub 2015 Nov 19.

  • Kim JH, Pullan AJ, Bradshaw LA, Cheng LK. Influence of body parameters on gastric bioelectric and biomagnetic fields in a realistic volume conductor. Physiol Meas. 2012 Apr;33(4):545-56. doi: 10.1088/0967-3334/33/4/545. Epub 2012 Mar 14.

  • Somarajan S, Cassilly S, Obioha C, Richards WO, Bradshaw LA. Effects of body mass index on gastric slow wave: a magnetogastrographic study. Physiol Meas. 2014 Feb;35(2):205-15. doi: 10.1088/0967-3334/35/2/205. Epub 2014 Jan 7.

  • Somarajan S, Muszynski ND, Obioha C, Richards WO, Bradshaw LA. Biomagnetic and bioelectric detection of gastric slow wave activity in normal human subjects--a correlation study. Physiol Meas. 2012 Jul;33(7):1171-9. doi: 10.1088/0967-3334/33/7/1171. Epub 2012 Jun 27.

MeSH Terms

Conditions

Gastroparesis

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Leonard A Bradshaw, PhD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor of Surgery

Study Record Dates

First Submitted

April 5, 2017

First Posted

June 6, 2017

Study Start

December 28, 2012

Primary Completion

May 19, 2021

Study Completion

May 19, 2021

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations